Innoviva
INVA
224 hedge funds and large institutions have $1.04B invested in Innoviva in 2018 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 79 increasing their positions, 71 reducing their positions, and 27 closing their positions.
11% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 71
7% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 27
0% more funds holding
Funds holding: 223 → 224 (+1)
0.05% less ownership
Funds ownership: 74.11% → 74.06% (-0.05%)
1% less call options, than puts
Call options by funds: $3.29M | Put options by funds: $3.31M
16% less capital invested
Capital invested by funds: $1.23B → $1.04B (-$194M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$91M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.67M |
| 3 |
WG
Winton Group
London,
United Kingdom
|
-$6.44M |
| 4 |
Morgan Stanley
New York
|
-$4.65M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$4.32M |
INVA Hedge Fund Activity: Q2 2018 in Review
224 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q2 2018, worth a combined $1.04B — down 16% from $1.23B a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new INVA positions and 27 closed out — a net gain of 2 holders — while 79 added to existing stakes and 71 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $22.4M. The largest seller was Fidelity Investments, cutting an estimated $91M.
- 224 institutional investors held Innoviva (INVA) as of Q2 2018, up from 223 in Q1 2018.
- Funds reported $1.04B of Innoviva stock for Q2 2018, down 16% quarter-over-quarter.
- 29 funds opened new Innoviva positions in Q2 2018 and 27 closed out, a net change of +2 holders.
- The largest Innoviva buyer in Q2 2018 was Point72 Asset Management, an estimated $22.4M added.
- The largest Innoviva seller in Q2 2018 was Fidelity Investments, an estimated $91M sold.
Based on aggregated 13F filings for Q2 2018.